Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
T riple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial
What is included MEDVi program pricing covers the following: Telehealth consultation with a licensed medical provider who reviews your health assessment and creates a personalized treatment plan Prescription medication shipped in temperature-controlled packaging directly to your door Free shipping on all medication deliveries 24/7 messaging support with your assigned care team for questions about dosing, side effects, or treatment adjustments Lab testing through Quest Diagnostics when medically indicated, at no additional cost Dosage adjustments coordinated through provider messaging as your treatment progresses Metabolic reporting that tracks relevant health markers over time The 24/7 messaging support is a genuine differentiator
Unlike many traditional approaches that focus on blood flow or hormone levels, PT-141 works through the central nervous system, targeting pathways in the brain involved in desire and arousal
NLRP3 is an inflammasome sensor protein that can perceive various DAMPs (danger-associated molecular patterns) and PAMPs (pathogen-associated molecular patterns)
NNMT inhibition increases availability of NAD+ and influences metabolic processes, allowing the body to burn more calories while suppressing additional glycogen and fat deposits
Side effects may diminish as the body becomes accustomed to the medication, but they can persist if treatment continues for an extended period
